Skip to main content

Table 1 The clinical features and genes expressed in the CIN and SCC groups

From: Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia

 

CIN

SCC

Z/X2

P

age

41.71 ± 9.31

49.87 ± 10.03

−3.575

0.000

gravidity

3.46 ± 1.84

4.00 ± 1.44

−1.720

0.085

parity

1.67 ± 1.34

2.30 ± 1.34

−2.377

0.017

HPV infection

 positive

47

28

/

1.000

 negative

5

2

  

menopause

  

13.610

0.000

 yes

9

17

  

 no

43

13

  

TCT

   

0.109

 CINII-(Normal/ASCUS)

16

4

/

 

 CINII+(LSIL/HSIL/SCC)

36

26

  

 CTNNB1

0.88 ± 0.24

4.23 ± 2.47

−1.637

0.102

TGFBR2

665.56 ± 357.49

15,156.14 ± 9065.91

−3.023

0.003

FOXO1

0.50 ± 0.30

0.10 ± 0.05

−3.110

0.002

PRKCI

0.56 ± 0.11

5.49 ± 2.66

−4.130

0.000

CSKN1A1

135.69 ± 81.39

4062.52 ± 1658.02

−3.783

0.000

TP73

75.39 ± 21.31

408.60 ± 145.24

−1.714

0.087

MUC2

1.89 ± 1.26

1.35 ± 0.70

−1.271

0.204

PIK3CA

7.28 ± 1.98

8.60 ± 3.22

−0.053

0.958

CCND2

1.40 ± 0.72

0.53 ± 0.25

−1.078

0.281

CTPB2

16.59 ± 6.14

599.16 ± 375.43

−2.089

0.037

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us